Search

Your search keyword '"Puurunen, Marja K"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Puurunen, Marja K" Remove constraint Author: "Puurunen, Marja K"
27 results on '"Puurunen, Marja K"'

Search Results

1. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels

2. Multi‐phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations

3. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study

5. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

6. Publisher Correction: Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study

10. Genetically predicted cortisol levels and risk of venous thromboembolism

11. Stroke genetics informs drug discovery and risk prediction across ancestries

12. Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes: A Mendelian Randomization Study

13. Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice

14. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans

17. Familial Hypercholesterolemia and Type 2 Diabetes in the Old Order Amish

18. Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice.

19. A genetic-association study of circulating coagulation factor VIII and von Willebrand factor levels

21. Familial Hypercholesterolemia and Type 2 Diabetes in the Old Order Amish.

22. CHADS 2 , CHA 2 DS 2 -VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention

23. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.

24. Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes

25. An engineered E. coliNissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans

26. Publisher Correction : Stroke genetics informs drug discovery and risk prediction across ancestries

27. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Catalog

Books, media, physical & digital resources